Search Results - David Gruben

  • Showing 1 - 3 results of 3
Refine Results
  1. 1
    Cover Image

    Characterization of Second‐Line Therapy After First JAK Inhibitor Use: Results From the CorEvitas Rheumatoid Arthritis Registry Autoría: Joshua F. Baker, Kristi V. Mizelle, Wassim Saikali, Page C. Moore, Hyung‐Joo Kang, David Gruben, Ahmed Shelbaya, Lori Stockert, Jacqueline O'Brien

    Published 2025
    Fuente: Wiley Open Access
    Tipo de material: Artículo Open Access
    Acceso al recurso
    Enlace del recurso

    Save to List
    Saved in:
  2. 2
    Cover Image

    Real‐World Data of Tofacitinib Versus Tumor Necrosis Factor Inhibitors in Taiwanese Patients With Rheumatoid Arthritis From a Drug‐Based Cohort Study Autoría: Song‐Chou Hsieh, Wei‐Sheng Chen, Jui‐Chieh Hu, Wan‐Yu Sung, Wen‐Chan Tsai, Hsiang‐Cheng Chen, Chung‐Ming Huang, Edward Kuo, David Gruben, Yi‐Hsing Chen

    Published 2026
    Fuente: Wiley Open Access
    Tipo de material: Artículo Open Access
    Acceso al recurso
    Enlace del recurso

    Save to List
    Saved in:
  3. 3
    Cover Image

    Tofacitinib for the Treatment of Juvenile Idiopathic Arthritis: Patient‐Reported Outcomes in a Phase 3, Randomized, Double‐Blind, Placebo‐Controlled Withdrawal Trial Autoría: Hermine I. Brunner, Ekaterina Alexeeva, Marcia Bandeira, Ruy Carrasco, Jeffrey Chaitow, Peter Chiraseveenuprapund, Tracy V. Ting, Muferet Erguven, Beth Gottlieb, Sheila Knupp Oliveira, Pooja N. Patel, Seza Ozen, Claudia Saad Magalhaes, Inmaculada Calvo Penadés, David Gruben, Rebecca Germino, Holly B. Posner, Lori Stockert, Alberto Martini, Daniel J. Lovell, Nicolino Ruperto

    Published 2025
    Fuente: Wiley Open Access
    Tipo de material: Artículo Open Access
    Acceso al recurso
    Enlace del recurso

    Save to List
    Saved in:

Search Tools: